| Christina Torre, | |
|
16 Pocono Rd Ste 317, Denville, NJ 07834-2908 | |
| (973) 627-2650 | |
| Not Available |
| Full Name | Christina Torre |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 7 Years |
| Location | 16 Pocono Rd Ste 317, Denville, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407389281 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 25MB10753700 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Clare's Hospital/ Denville Campus | Denville, NJ | Hospital |
| Morristown Medical Center | Morristown, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Consensus Medical Group Llc | 2961748181 | 137 |
News Archive
As a part of its new initiative, Expanding Access to Opioid Substitution Therapy (OST) for People Who Inject Drugs in Eastern Europe and Central Asia (EECA), the International AIDS Society (IAS) will launch a Virtual Knowledge Centre (VKC) in partnership with the Ukrainian Institute on Public Health Policy.
Some of the most important weight-loss drugs work by enhancing the effect of the brain chemical serotonin.
Recently, a group of researchers analyzed 122 pregnant women and their neonates at the time of birth. All the women studied received 1 or both doses of a messenger RNA (mRNA)-based vaccine for COVID-19. Of the 122 women part of the study, 55 had received only the first dose of the vaccine while 67 women had received both doses of the mRNA vaccine by the time they gave birth; 85 women had received the Pfizer-BioNTech vaccine, and 37 women received the Moderna vaccine. The study is published on the preprint server, bioRxiv.
Xybion Corporation, leading provider of preclinical R&D solutions announced today that CTI Biotechnology in Suzhou, China has implemented Xybion's Pristima 7 Preclinical Suite. Pristima® was selected after an exhaustive evaluation of top selling preclinical software systems on the market.
A new survey released today by the American Pain Foundation (APF) reveals that breakthrough cancer pain — sudden, temporary flares of severe pain that occur even when pain medication is used — is one of the most challenging aspects of having cancer, according to three out of four (75 percent) U.S. adults who have ever been diagnosed with cancer and experience this type of pain.
› Verified 7 days ago
| Entity Name | Skylands Medical Group, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396841508 PECOS PAC ID: 6800882242 Enrollment ID: O20040422000067 |
News Archive
As a part of its new initiative, Expanding Access to Opioid Substitution Therapy (OST) for People Who Inject Drugs in Eastern Europe and Central Asia (EECA), the International AIDS Society (IAS) will launch a Virtual Knowledge Centre (VKC) in partnership with the Ukrainian Institute on Public Health Policy.
Some of the most important weight-loss drugs work by enhancing the effect of the brain chemical serotonin.
Recently, a group of researchers analyzed 122 pregnant women and their neonates at the time of birth. All the women studied received 1 or both doses of a messenger RNA (mRNA)-based vaccine for COVID-19. Of the 122 women part of the study, 55 had received only the first dose of the vaccine while 67 women had received both doses of the mRNA vaccine by the time they gave birth; 85 women had received the Pfizer-BioNTech vaccine, and 37 women received the Moderna vaccine. The study is published on the preprint server, bioRxiv.
Xybion Corporation, leading provider of preclinical R&D solutions announced today that CTI Biotechnology in Suzhou, China has implemented Xybion's Pristima 7 Preclinical Suite. Pristima® was selected after an exhaustive evaluation of top selling preclinical software systems on the market.
A new survey released today by the American Pain Foundation (APF) reveals that breakthrough cancer pain — sudden, temporary flares of severe pain that occur even when pain medication is used — is one of the most challenging aspects of having cancer, according to three out of four (75 percent) U.S. adults who have ever been diagnosed with cancer and experience this type of pain.
› Verified 7 days ago
| Entity Name | Consensus Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811466881 PECOS PAC ID: 2961748181 Enrollment ID: O20190109001851 |
News Archive
As a part of its new initiative, Expanding Access to Opioid Substitution Therapy (OST) for People Who Inject Drugs in Eastern Europe and Central Asia (EECA), the International AIDS Society (IAS) will launch a Virtual Knowledge Centre (VKC) in partnership with the Ukrainian Institute on Public Health Policy.
Some of the most important weight-loss drugs work by enhancing the effect of the brain chemical serotonin.
Recently, a group of researchers analyzed 122 pregnant women and their neonates at the time of birth. All the women studied received 1 or both doses of a messenger RNA (mRNA)-based vaccine for COVID-19. Of the 122 women part of the study, 55 had received only the first dose of the vaccine while 67 women had received both doses of the mRNA vaccine by the time they gave birth; 85 women had received the Pfizer-BioNTech vaccine, and 37 women received the Moderna vaccine. The study is published on the preprint server, bioRxiv.
Xybion Corporation, leading provider of preclinical R&D solutions announced today that CTI Biotechnology in Suzhou, China has implemented Xybion's Pristima 7 Preclinical Suite. Pristima® was selected after an exhaustive evaluation of top selling preclinical software systems on the market.
A new survey released today by the American Pain Foundation (APF) reveals that breakthrough cancer pain — sudden, temporary flares of severe pain that occur even when pain medication is used — is one of the most challenging aspects of having cancer, according to three out of four (75 percent) U.S. adults who have ever been diagnosed with cancer and experience this type of pain.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christina Torre, 33 Newton Sparta Rd, Newton, NJ 07860-2764 Ph: (973) 579-3799 | Christina Torre, 16 Pocono Rd Ste 317, Denville, NJ 07834-2908 Ph: (973) 627-2650 |
News Archive
As a part of its new initiative, Expanding Access to Opioid Substitution Therapy (OST) for People Who Inject Drugs in Eastern Europe and Central Asia (EECA), the International AIDS Society (IAS) will launch a Virtual Knowledge Centre (VKC) in partnership with the Ukrainian Institute on Public Health Policy.
Some of the most important weight-loss drugs work by enhancing the effect of the brain chemical serotonin.
Recently, a group of researchers analyzed 122 pregnant women and their neonates at the time of birth. All the women studied received 1 or both doses of a messenger RNA (mRNA)-based vaccine for COVID-19. Of the 122 women part of the study, 55 had received only the first dose of the vaccine while 67 women had received both doses of the mRNA vaccine by the time they gave birth; 85 women had received the Pfizer-BioNTech vaccine, and 37 women received the Moderna vaccine. The study is published on the preprint server, bioRxiv.
Xybion Corporation, leading provider of preclinical R&D solutions announced today that CTI Biotechnology in Suzhou, China has implemented Xybion's Pristima 7 Preclinical Suite. Pristima® was selected after an exhaustive evaluation of top selling preclinical software systems on the market.
A new survey released today by the American Pain Foundation (APF) reveals that breakthrough cancer pain — sudden, temporary flares of severe pain that occur even when pain medication is used — is one of the most challenging aspects of having cancer, according to three out of four (75 percent) U.S. adults who have ever been diagnosed with cancer and experience this type of pain.
› Verified 7 days ago
Dr. Michael Gerard Gironta, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 16 Pocono Rd, Suite 313, Denville, NJ 07834 Phone: 973-625-0112 Fax: 973-625-0721 | |
Liliana Moreno Garcia, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 25 Pocono Rd, Denville, NJ 07834 Phone: 848-245-4041 | |
Audrey M Hamilton, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 23 Pocono Rd, Denville, NJ 07834 Phone: 646-227-3813 | |
Dr. Murray Las, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 56 Diamond Spring Rd, Denville, NJ 07834 Phone: 973-625-1000 Fax: 973-625-9122 | |
Richard Finkel, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 16 Pocono Rd, Ste 209, Denville, NJ 07834 Phone: 973-625-5651 | |
Alan S Mufson, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 16 Pocono Road, Suite 317, Denville, NJ 07834 Phone: 973-627-2650 Fax: 973-627-8383 | |
Michael Nicolai, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 16 Pocono Road, Suite 317, Denville, NJ 07834 Phone: 973-627-2650 Fax: 973-627-8383 |